Dimensional Fund Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Dimensional Fund Advisors’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,073	Closed	-$53K	–	3410
2019 Q3	$53K	Hold	1,073	–	–	﹤0.01%	3383
2019 Q2	$98K	Hold	1,073	–	–	﹤0.01%	3394
2019 Q1	$158K	Hold	1,073	–	–	﹤0.01%	3338
2018 Q4	$169K	Hold	1,073	–	–	﹤0.01%	3306
2018 Q3	$263K	Buy	1,073 +76	+8%	+$18K	﹤0.01%	3271
2018 Q2	$223K	Hold	997	–	–	﹤0.01%	3234
2018 Q1	$244K	Buy	+997	New	+$262K	﹤0.01%	3200

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors's DMK Position: Q4 2019 in Review

Dimensional Fund Advisors sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2019, closing a stake of 1,073 shares — an estimated $53K sold.

Dimensional Fund Advisors first reported a position in DMK in Q1 2018 and held it in 7 quarters. The position peaked at $263K in Q3 2018. 38 funds tracked by Wall St. Rank hold DMK as of Q4 2019.

Dimensional Fund Advisors reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2019 after selling out during the quarter.
Dimensional Fund Advisors sold 1,073 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2019, an estimated $53K.
Dimensional Fund Advisors first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2018 and held it in 7 quarters.
Dimensional Fund Advisors's DMK Pharmaceuticals Corporation Common Stock position peaked at $263K in Q3 2018.
38 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2019.

Based on Dimensional Fund Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.